Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated March 11, 2024, with respect to the financial statements of ORIC Pharmaceuticals, Inc., incorporated herein by reference.
| /s/ KPMG LLP |
San Diego, California March 29, 2024 |
